• 
• 
• 

FDA News and Drug Updates

FDA News - May 2018

Welcome to the Third Annual Oncology Guide to New FDA Approvals

FDA Approvals in 2017 Represent a 21-Year High

Supportive Care

Supportive Care Updates from ASCO 2017 Highlighted at New Orleans Summer Cancer Meeting

Meg Barbor, MPH

A Taxing Consequence: Taxane Acute Pain Syndrome

Mark L. Zangardi, PharmD, BCOP

Helping Adolescents and Young Adults Confront Mortality

Meg Barbor, MPH

View All Supportive Care Articles

Lung Cancer

Alunbrig (Brigatinib) Approved for Metastatic NSCLC with ALK Mutation

Lisa A. Raedler, PhD, RPh, Medical Writer

Brigatinib May Prolong Survival After Progression of Crizotinib-Refractory, ALK-Positive NSCLC

CheckMate-227 Meets Co-Primary End Point of PFS with Nivolumab/Ipilimumab Combination in NSCLC, Confirms TMB as Viable Biomarker

View All Lung Cancer Articles

Conference Correspondent

Palliative Care Use Dismal Among Patients with Hematologic Malignancies

Oral Multiple Myeloma Medication Linked to Decreased Productivity Loss

Ivosidenib, New IDH1 Inhibitor, Elicits Complete Response in Relapsed Acute Myeloid Leukemia

“Superhero” Navigators Convene at the 8th Annual Navigation & Survivorship Conference

Silent Patients Find Their Voices Through an Advocate’s Journey

View All Conference Correspondent Articles

Most Popular Articles

Giving People Hope as an Oncology Nurse

Laura Mulderrig, BSN, RN, OCN

Video Library - ONE Award, Video

Oncology Palliative Care at Penn Nursing Cancer

TON - May 2018, Vol 11, No 2 - Cancer Center Profile, Palliative Care

AONN+ Takes a Seat at the Table for the Biden Cancer Initiative

TON - May 2018, Vol 11, No 2 - AONN+ News

Strategies to Address the Long-Term Financial Burden of Cancer in Survivors

Meg Barbor, MPH

TON - May 2018, Vol 11, No 2 - Survivorship, Financial/Insurance Information